DS28120313 manufacturers
- DS28120313
-
- $1610.00
-
2026-05-11
- CAS:2146177-09-3
- Purity:
- Supply Ability: 10g
|
| | DS28120313 Basic information |
| Product Name: | DS28120313 | | Synonyms: | DS28120313;Methyl Ester N-[6-(3-Cyclopropyl-5-methyl-1H-pyrazol-4-yl)-1H-indazol-4-yl]carbamic Acid;DS-28120313,DS28120313;Carbamic acid, N-[6-(3-cyclopropyl-5-methyl-1H-pyrazol-4-yl)-1H-indazol-4-yl]-, methyl ester | | CAS: | 2146177-09-3 | | MF: | C16H17N5O2 | | MW: | 311.34 | | EINECS: | | | Product Categories: | | | Mol File: | 2146177-09-3.mol |  |
| | DS28120313 Chemical Properties |
| Boiling point | 538.7±50.0 °C(Predicted) | | density | 1.443±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | form | Solid | | pka | 12.80±0.43(Predicted) | | color | Off-white to light yellow |
| | DS28120313 Usage And Synthesis |
| Uses | Methyl Ester N-[6-(3-Cyclopropyl-5-methyl-1H-pyrazol-4-yl)-1H-indazol-4-yl]carbamic Acid is used in preparation and hepcidin production inhibitory activity of disubstituted Indazole derivatives. | | in vivo | DS28120313 (deliver orally; 30 mg/kg; 30 min before IL-6 administration) inhibits hepcidin production and reduces the blood hepcidin level in IL-6 induced acute inflammatory C57BL/6 mouse model[1]. |
| | DS28120313 Preparation Products And Raw materials |
|